- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↑ 0.32%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH and its peers as on 16 July, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 20.96% | 0.32% | 1.98% | 8.18% | 18.68% | 16.06% | 25.23% | 17.65% | 25.64% | 14.98% |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -5.79% | 0.34% | -0.19% | 0.79% | -1.02% | -8.29% | 8.13% | 13.6% | 16.14% | 14.27% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -2.28% | 0.74% | 0.78% | 1.9% | 2.07% | 0.62% | 10.55% | 10.7% | 13.11% | 12.55% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | 4.06% | -0.54% | 0.3% | 0.73% | 4.54% | 1.76% | 17.69% | 18.59% | 19.41% | 15.66% |
| SBI PSU Fund - DIRECT PLAN - GROWTH | 1.71% | 0.02% | -0.45% | -2.01% | -4.9% | 7.22% | 26.27% | 24.34% | 19.56% | 14.98% |
| SBI TECHNOLOGY OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -16.33% | 0.23% | 2.28% | 3.46% | -1.14% | -11.5% | 8.62% | 8.95% | 17.61% | 16.57% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -12.62% | 2.71% | -8.64% | 0.65% | 68.71% | 20.05% | -4.78% | 40.03% | 43.86% | -2.89% |
Discrete returns (monthly)
| Month | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -1.93% | 2.61% | 0.63% | -2.82% | -3.5% | 6.36% | -3.54% | 5.89% | 4.65% | 8.07% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|---|
| Returns | 19.06% | 12.18% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 98.16% | 0.07% (Arbitrage: 0.00%) | 0.00% | 0.00% | 1.77% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 12.11% |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 6.59% |
| Acutaas Chemicals Ltd. | ACUTAAS (INE00FF01025) | Pharmaceuticals & Biotechnology | 5.67% |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 5.48% |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 4.97% |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 4.10% |
| Aster DM Healthcare Ltd. | ASTERDM (INE914M01019) | Healthcare Services | 3.96% |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 3.74% |
| Aether Industries Ltd. | AETHER (INE0BWX01014) | Chemicals & Petrochemicals | 3.56% |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 3.33% |
| Anthem Biosciences Ltd. | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 3.17% |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 3.16% |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 2.93% |
| Laurus Labs Ltd. | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 2.93% |
| Jupiter Life Line Hospitals Ltd. | JLHL (INE682M01012) | Healthcare Services | 2.84% |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 2.61% |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 2.57% |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 2.50% |
| Krishna Institute of Medical Sciences Ltd. | KIMS (INE967H01025) | Healthcare Services | 2.45% |
| Sai Life Sciences Ltd. | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 2.24% |
| Ajanta Pharma Ltd. | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 2.07% |
| Sudeep Pharma Ltd. | SUDEEPPHRM (INE0QPI01025) | Pharmaceuticals & Biotechnology | 1.98% |
| Abbott India Ltd. | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 1.91% |
| Polymedicure Ltd. | POLYMED (INE205C01021) | Healthcare Equipment & Supplies | 1.88% |
| Concord Biotech Ltd. | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 1.80% |
| Nephrocare Health Service Pvt. Ltd. | NEPHROPLUS (INE428V01029) | Healthcare Services | 1.00% |
| Cohance Lifesciences Ltd. | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 0.89% |
| Sanofi Consumer Healthcare India Ltd. | SANOFICONR (INE0UOS01011) | Pharmaceuticals & Biotechnology | 0.63% |
| Gufic Biosciences Ltd. | GUFICBIO (INE742B01025) | Pharmaceuticals & Biotechnology | 0.54% |
| Vijaya Diagnostic Centre Ltd. | VIJAYA (INE043W01024) | Healthcare Services | 0.53% |
| Medplus Health Services Ltd. | MEDPLUS (INE804L01022) | Retailing | 0.41% |
| Rainbow Children's Medicare Ltd. | RAINBOW (INE961O01016) | Healthcare Services | 0.35% |
| Corona Remedies Ltd. | CORONA (INE02ZQ01018) | Pharmaceuticals & Biotechnology | 0.29% |
| Lonza Group | (US54338V1017) | Pharmaceuticals & Biotechnology | 2.97% |
Debt
| Name | Rating | Weight % |
|---|---|---|
| 364 DAY T-BILL 19.11.26 | Sovereign | 0.07% |
Portfolio data is as on date 31 March, 2026
NAV history
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 16 July, 2026 | 585.8266 | 0.32% |
| 15 July, 2026 | 583.9614 | 0.63% |
| 14 July, 2026 | 580.2884 | 0.53% |
| 13 July, 2026 | 577.2386 | 0.09% |
| 10 July, 2026 | 576.7078 | 0.39% |
| 9 July, 2026 | 574.4530 | 1.55% |
| 8 July, 2026 | 565.6662 | -0.89% |
| 7 July, 2026 | 570.7674 | -1.13% |
| 6 July, 2026 | 577.3126 | -0.36% |
| 3 July, 2026 | 579.3971 | 0.98% |
| 2 July, 2026 | 573.7611 | 0.95% |
| 1 July, 2026 | 568.3644 | -0.26% |
| 30 June, 2026 | 569.8190 | 0.64% |
| 29 June, 2026 | 566.1793 | 1.18% |
| 25 June, 2026 | 559.5790 | -0.17% |
| 24 June, 2026 | 560.5165 | 0.28% |
| 23 June, 2026 | 558.9789 | 0.63% |
| 22 June, 2026 | 555.4799 | 0.83% |
| 19 June, 2026 | 550.8819 | 0.67% |
| 18 June, 2026 | 547.2225 | 1% |
| 17 June, 2026 | 541.7841 | 0.05% |
| 16 June, 2026 | 541.5241 | -0.2% |
| 15 June, 2026 | 542.6128 | -0.55% |
| 12 June, 2026 | 545.6258 | 0.51% |
| 11 June, 2026 | 542.8310 | 0.36% |
| 10 June, 2026 | 540.8745 | -0.34% |
| 9 June, 2026 | 542.7383 | 0.93% |
| 8 June, 2026 | 537.7611 | -0.02% |
| 5 June, 2026 | 537.8663 | 0.94% |
| 4 June, 2026 | 532.8558 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The latest NAV of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH is 585.8266 as on 16 July, 2026.What are YTD (year to date) returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The YTD (year to date) returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 20.96% as on 16 July, 2026.What are 1 year returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 1 year returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 16.06% as on 16 July, 2026.What are 3 year CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 3 year annualized returns (CAGR) of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 25.23% as on 16 July, 2026.What are 5 year CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 5 year annualized returns (CAGR) of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 17.65% as on 16 July, 2026.What are 10 year CAGR returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 10 year annualized returns (CAGR) of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 17.65% as on 16 July, 2026.